Thus, we identified two target genes of miR‐30d, including MTDH, a totally novel identified molecule involved in PASMC function, and PDE5A, a well‐known molecule that can be targeted in PAH treatment. The gene discussed is PDE5A; the disease is pulmonary arterial hypertension.